HKU Scholars Hub: Browsing DSpace

Browsing by Author Zeuzem, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 5 to 12 of 12 < previous

	Title	Author(s)	Issue Date	Views
	Optimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients Proceeding/Conference:Journal of Hepatology	Zeuzem, S Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N	2006	128
	Prolonged efficacy and safety of 3 years of continuous telbivudine treatment in pooled data from globe and 015 studies in chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology	Hsu, CW Chen, YC Liaw, YF Gane, E Manns, M Zeuzem, S Wang, Y Lai, CL Hou, J Leung, N Bzowej, N Niu, J Jia, J Hwang, SG Cakaloglu, Y Ren, H Papatheodoridis, G Chen, Y Bao, W Lopez, P	2009	118
	Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Journal:New England Journal of Medicine	Feld, JJ Jacobson, IM Hézode, C Asselah, T Ruane, PJ Gruener, N Abergel, A Mangia, A Lai, CL Chan, HLY Mazzotta, F Moreno, C Yoshida, E Shafran, SD Towner, WJ Tran, TT McNally, J Osinusi, A Svarovskaia, E Zhu, Y Brainard, DM McHutchison, JG Agarwal, K Zeuzem, S	2015	110
	Sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in genotype 1, 2, 4, 5, 6 HCV patients: ASTRAL-1 study Proceeding/Conference:Hepatology International	Chan, HLY Feld, JJ Agarwal, K Hezode, C Asselah, T Ruane, PJ Gruener, N Abergel, A Mangia, A Lai, CL Mazzotta, F Moreno, C Yoshida, E Shafran, SD Towner, WJ Tran, TT McNally, J Brainard, DM Jacobson, IM Zeuzem, S	2016	68
	Telbivudine Globe Trial: Maximal Early HBV Suppression is Predictive of Optimal Two-year Efficacy in Nucleoside-treated Hepatitis B Patients Proceeding/Conference:Hepatology	DiBisceglie A, A Lai, CL Gane, E Chen, YC Thongsawat, S Wang, YM Chen, YG Heathcote, EJ Zeuzem, S Rasenack, J Bzowej, N Han, SH Naoumov, N Hwang, SG Lim, SG Chao, GC Fielman, BA Brown, NA Study Group The GLOBE,	2006	138
	Telbivudine versus lamivudine in patients with chronic hepatitis B Journal:New England Journal of Medicine	Lai, CL Gane, E Liaw, YF Hsu, CW Thongsawat, S Wang, Y Chen, Y Heathcote, EJ Rasenack, J Bzowej, N Naoumov, NV Di Bisceglie, AM Zeuzem, S Moon, YM Goodman, Z Chao, G Constance, BF Brown, NA	2007	182
	The case for simplifying and using absolute targets for viral hepatitis elimination goals Journal:Journal of Viral Hepatitis	Razavi, H Blach, S Razavi-Shearer, D Abaalkhail, F Abbas, Z Abdallah, A Abrao Ferreira, P Abu Raddad, LJ Adda, D Agarwai, K Aghemo, A Ahmed, A Al‐Busafi, SA Al‐hamoudi, W Al‐Kaabi, S Al‐Romaihi, H Aljarallah, B AlNaamani, K Alqahtani, S Alswat, K Altraif, I Thein, H-H Thompson, P Tolmane, L Toy, M Valantinas, J Van de Vijver, D Vélez‐Möller, P Vince, A Waked, I Wang, S Wedemeyer, H Wong, V Xie, Q Yamada, S Yang, H-I Yesmembetov, K Yilmaz, Y Younossi, Z Yu, M-L Yuen, RMF Yurdaydin, C Yusuf, A Zekry, A Zeuzem, S	2021	3
	Two-year Results from the Globe Trial in Patients with Hepatitis B: Greater Clinical and Antiviral Efficacy for Telbivudine (LdT) vs Lamivudine Proceeding/Conference:Hepatology	Lai, CL Gane, E Hsu, CW Thongsawat, S Wang, YM Chen, YG Heathcote, EJ Rasenack, J Bzowej, N Naoumov, N Zeuzem, S Di Bisceglie, A Chao, GC Barbara, A Constance, F Brown, NA Study Group The GLOBE.,	2006	139

Showing results 5 to 12 of 12 < previous